In our clinical assessment of the impact of serial D+Q injections on development of pelvic organ prolapse, no significant differences were seen in vaginal bulge height in either WT or Fbln-5-/- mice receiving D+Q injections compared to control animals. This evidence concerns the gene FBLN5 and pelvic organ prolapse.